Explore the Global Hematopoietic Stem Cell Transplantation Market — Key Trends, Regional Growth, Top Players, and 10-Year Forecast from 2026 to 2036

Future Market Insights

Hematopoietic Stem Cell Transplantation Market

Key Insight

Hematopoietic stem cell transplantation sales will strengthen through 2036, anchored by allogeneic transplants at 57.3% of the transplant type segment in 2026. Acute Myeloid Leukemia leads the application segment with a 38.5% share. The market is projected to reach USD 8.8 billion in 2026 and USD 18.61 billion by 2036.

April 29, 2026

Anurag Sharma

298 Pages

Cite this Report

Hematopoietic Stem Cell Transplantation Market

https://www.futuremarketinsights.com/reports/hematopoietic-stem-cell-transplantation-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

CellGenix GmbH
Lonza
Medipost
Mesoblast Ltd
Miltenyi Biotec
Pluristem Therapeutics Inc
Pluristem Therapeutics Inc. (Israel)
Regen Biopharma Inc
STEMCELL Technologies Inc
L'Oréal
Taiga Biotechnologies
Takara Bio Inc
Takeda Pharmaceutical Company Limited

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Hematopoietic Stem Cell Transplantation Market

Key Players

Similar Industry Reports